Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Charles River Laboratories entered a collaboration with Australia’s Magellan Stem Cells to support development of Magellan’s stem cell therapies. Charles River will provide cGMP viral safety testing using next-generation sequencing to support regulatory-ready quality control for cell therapies. Magellan is preparing a
For best results when printing this announcement, please click on link below: Charles River Collaborates with Magellan Stem Cells to Advance Stem Cell and Regenerative Medicine Development Collaboration leverages next-generation sequencing (NGS) services to advance development and commercialization of an off-the-shelf